Treatments for pulmonary arterial hypertension (PAH) - a type of high blood pressure that affects arteries in the lungs and in the heart - have improved significantly over the past 15 to 20 years and researchers at the University of Cincinnati have been at the forefront of those improvements.
The result of a series of studies UC researchers were part of have allowed new medications to come to market for patients with PAH.
"Pulmonary arterial hypertension is a severe and life-limiting vascular disease and initially the only therapy for this condition was a continuous IV infusion," says Jean Elwing, MD, in the Department of Pulmonary, Critical Care and Sleep Medicine at the UC College of Medicine. "Since 2007, there were several studies which the UC pulmonary hypertension program was actively involved in to evaluate an oral form of prostacyclin," she said, referring to a drug that inhibits platelet activation and is also an effective vasodilator that opens or dilates blood vessels. "These studies allowed this medication to become [Food and Drug Administration] approved for use in our patients."
Elwing says several factors contribute to her passion for researching PAH. One is the science and physiology of the disease, which she describes as complex and delicate and very challenging to manage.
"Secondly, you've taken a disease that in the 1990s was a death sentence and now you've made it a condition we can live with," Elwing says. "That has been extremely fascinating, amazing to work through and be part of developing the drugs that made it happen."
Another key component of her passion for fighting this disease is the PAH patients.
"You get to know these people. You get to help them through many life events while you're managing their disease so they can experience those moments," Elwing says. "You want them to experience the birth of their grandchild, their daughter going to high school, their kid finishing grade school, and we couldn't do this without these medications."
Patient Hammond is thankful for the medications as well as the health care providers who have helped him along the way.
"Outside of being old, I feel pretty good and all of it I attribute to the doctors I have, from my rheumatologist to my cardiologist to my pulmonologist," Hammond says. "I think Dr. Elwing has done wonders for me. I can never thank her enough for keeping me alive."
Lead photo/Colleen Kelley/UC Marketing + Brand
